Biology subjects

Frysz, M.

Publications and source records attributed to Frysz, M..

3 recordsLinked to original sources

bioRxiv2025

The genetic architecture of trabecular bone score and association with fracture: a genome-wide association and meta-analysis

BackgroundTrabecular bone score (TBS) is a texture-based measurement derived from DXA scans, which describes the distribution of mineral across the vertebral bodies. Identifying its genetic determinants is crucial for enhancing understanding of its biological basis and clarifying its relationship with fracture risk. MethodsWe conducted a large-scale genome-wide association study (GWAS) of TBS from 44,767 participants (95.08% European ancestry). Sex heterogeneity was assessed through sex-stratified GWAS. Post-GWAS analyses included functional annotation, gene-set enrichment analysis, and cis-expression quantitative trait locus (cis-eQTL) colocalization. Two-sample and multivariable Mendelian randomization (MR) were employed to investigate the causal effect of TBS on fractures. FindingsWe identified 33 independent variants associated with TBS, which explained 4.06% of TBS phenotypic variance. All the discovered signals map to previously identified BMD-associated loci. Additionally, we identified genetic variants in the RAB11FIP3 locus that exhibited a sex-heterogeneous effect, being associated with TBS exclusively in males. Functional annotation and colocalization identified functional genes related to TBS. The two-sample and multivariable MR analyses indicated that TBS potentially has an independent causal effect on fracture risk. InterpretationOur study unveiled 33 independent loci associated with TBS, all in BMD-associated loci. One locus was further identified as associated with TBS only in males. MR results suggested that genetically derived TBS may be causally associated with fracture risk at different sites, potentially beyond BMD. This study provides insights into the TBS genetic architecture and uncovers its potential clinical applications in fracture risk prediction. FundingAll funding information can be found in the Acknowledgements section. Research in contextO_ST_ABSEvidence before this studyC_ST_ABSOsteoporosis is a common disease prevalent in older adults, mainly diagnosed by low bone mineral density and disruption of bone architecture. While the genetic determinants of bone mass have been well studied, the genetic architecture of bone features beyond BMD remains largely unknown. Added value of this studyThis study presents a large genome-wide association meta-analysis of the trabecular bone score (TBS), a measurement of trabecular distribution of bone mineralization across vertebral bodies. Our study identified 33 independent variants associated with TBS and one association signal only in males. Functional annotation highlighted crucial genes related to TBS. The two-sample and multivariable Mendelian randomization (MR) analyses suggested that TBS may be causally linked with fracture risk, potentially independent of BMD. Implications of all the available evidenceOur study represents an expansion of the traditional bone density phenotype used in most previous skeletal genetic studies. Based on the findings that all of the significant loci for TBS have been previously identified in GWAS of BMD, we conclude that TBS-associated variants have pleiotropic effects affecting not only mineral density but also the distribution patterns of minerals in the cancellous bone. Continuing to perform genetic studies of new skeletal phenotypes beyond BMD could ultimately impact the management and prediction of osteoporosis patients.

genomics↗

bioRxiv2024

Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease

Musculoskeletal diseases are a major health burden. Development of bone-active therapies has been hindered by limited understanding of the cells and genes that regulate the skeleton. We exploited the value of cross-species analysis and developed single-cell methodologies in skeletal tissues to define the critical endosteal compartment that regulates bone turnover. Thirty-four distinct cell types were identified, and disease-relevant cells prioritised by enrichment for rare skeletal disorder genes and bone mineral density-associated genes in an extended UK Biobank GWAS. Functional validation was undertaken in over one thousand genetically modified mouse models. Endothelial and vascular smooth muscle cells were identified as novel skeletal disease-relevant cells alongside osteoblast, chondrocyte and osteoclast cell lineages. Hundreds of cell-specific genes with unappreciated roles in skeletal pathophysiology were identified. This comprehensive cellular and molecular framework underpins skeletal physiology and disease, and will help prioritise new therapeutic targets to accelerate development of novel therapies to treat musculoskeletal disease.

genetics↗

bioRxiv2019

Puberty timing and adiposity change across childhood and adolescence: disentangling cause and consequence

ObjectiveTo better understand if earlier puberty is more likely a result of adiposity gain in childhood than a cause of adiposity gain in adulthood.\n\nDesignProspective birth cohort study.\n\nSettingPopulation based study of children born in 1991/1992 in Bristol UK (Avon Longitudinal Study of Parents and Children (ALSPAC)).\n\nParticipants4,186 participants (2,176 female and 1,990 male) of predominantly White ethnicity with 18,232 repeated measures throughout follow-up.\n\nExposures & outcomesRepeated measures of height from 5y to 20y to identify puberty timing (age at peak height velocity) and repeated measures of dual-energy X-ray absorptiometry-derived fat mass from age 9y to 18y, modelled separately in females and males using models based on chronological age and time before and after puberty onset.\n\nResultsMean age at peak height velocity was 11.7y (standard deviation (SD)=0.8y) for females and 13.6y (SD=0.9y) for males. In adjusted models of fat mass by chronological age, a one-year later age at peak height velocity was associated with 20.4% (95% Confidence Interval (CI): 18.5% to 22.3%) and 22.8% (95% (CI): 20.7% to 24.8%) lower fat mass in females and males respectively at 9y. These differences were smaller at age 18y: 7.8% (95% (CI):5.9% to 9.6%) and 11.9% (95% (CI): 9.1%, to 14.7%) lower fat mass in females and males respectively per year later age at peak height velocity. Trajectories of fat mass by time before and after puberty onset provided strong evidence for an association of pre-pubertal fat mass with puberty timing, and little evidence of an association of puberty timing with post-pubertal changes in fat mass in females. In males, findings were less clear before puberty though there was some evidence for an association of earlier puberty timing with great post-pubertal gain in fat mass.\n\nConclusionsEarlier puberty is more likely a result of adiposity gain in childhood than a cause of adiposity gain in adulthood in females. In males early to puberty, differences in fat mass after puberty are driven partially by tracking of adiposity from early childhood but also greater gains in post-pubertal adiposity. Reducing levels of childhood adiposity may help prevent both earlier puberty, later life adiposity and their associated adverse social, mental and physical health sequelae.

epidemiology↗